<DOC>
	<DOCNO>NCT02036073</DOCNO>
	<brief_summary>EPO safely use prevent preterm anemia recent study show neuroprotective effect . Our hypothesis EPO could prevent preterm brain injury . The aim study include : investigate safety efficacy EPO use 500u/kg high dose anemia treatment ( 250u/kg ) ; evaluate effect EPO neurodevelopment preterm infant ; detect biological indicator explore neuroprotective mechanism EPO .</brief_summary>
	<brief_title>Effect Erythropoietin Preterm Brain Injury</brief_title>
	<detailed_description>Periventricular leukomalacia ( PVL ) one common brain injury occur preterm infant , relate development cerebral palsy . The current therapy supportive maintain live sign stable . There effective therapeutic strategy preterm brain injury . Erythropoietin ( EPO ) show protective hypoxic-ischemic inflammatory injury animal model brain injury , clinical trial neonatal hypoxic ischemic brain injury . Furthermore , recombinant human Epo ( rhEpo ) widely use preterm infant prevent treat anemia prematurity past decade . It consider safe well tolerated preterm infant . However , conclusion yet EPO effect prevent preterm brain injury . The purpose study whether rhEpo ( 500 U/kg ) give preterm infant ( gestation age &lt; 32 week ) within 24h birth subsequently day for2 week posse neuroprotective property . Very preterm infant gestational age &lt; 32 week admit NICU eligible enrollment . After informed consent obtain , infant randomly assign either EPO group vehicle group . The primary short-term outcome measure brain injury ( intraventricular hemorrhage ( IVH ) periventricular leukomalacia ( PVL ) ) ROP . The long term outcomes whether rhEpo preterm infant finally improve neurodevelopmental outcome 18 month correct age .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Preterm infant admit NICU gestational age &lt; 32 week birth weight &lt; 1500g le 72hours age 1 . Infants genetic metabolic diseases 2 . Congenital abnormality 3 . Pneumothorax 4 . Grade IIIIV intracranial hemorrhage</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>72 Days</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>erythropoietin</keyword>
	<keyword>preterm</keyword>
	<keyword>brain injury</keyword>
	<keyword>cerebral palsy</keyword>
	<keyword>PVL</keyword>
</DOC>